These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 6954300)

  • 1. [Clinical studies on immunopotent activities in the sera of children with acute lymphoblastic leukemia (ALL)].
    Iguchi K; Akane H; Tanimoto Y; Matsuda T; Sakurai M; Izawa T; Nishioka K
    Rinsho Ketsueki; 1982 Jan; 23(1):53-60. PubMed ID: 6954300
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibody-dependent and spontaneous cell-mediated cytotoxicity in children with acute lymphoblastic leukemia.
    Láng I; Zoltán E; Révész T; Gergely P; Schuler D; Petranyi G
    Allergol Immunopathol (Madr); 1982; 10(5):341-5. PubMed ID: 6962671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Disease- and therapy-related immunodefects in acute lymphoblastic leukemia (a.l.l.) (author's transl)].
    Eife R
    Klin Padiatr; 1978 Jan; 190(1):28-43. PubMed ID: 305501
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cellular immunity in children with acute lymphoblastic leukemia].
    Gebauer E; Stanković G; Krstić A
    Med Pregl; 1980; 33(9-10):387-90. PubMed ID: 6936608
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cellular and humoral immunity in children with lymphoblastic leukemia].
    Jagielski P; Litwin J; Rokicka-Milewska R; Derulska D; Madaliński K
    Pediatr Pol; 1981 Sep; 56(9):993-1001. PubMed ID: 6976553
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison of immunologic indicators in children with a favorable and unfavorable prognosis in acute lymphoblastic leukemia].
    Fabianová J; Mracková E; Zavázal V
    Cesk Pediatr; 1981 Oct; 36(10):573-5. PubMed ID: 6946867
    [No Abstract]   [Full Text] [Related]  

  • 7. [Data on the immunological profile of children with acute lymphoblastic leukemia treated by immunotherapy].
    Esposito L; Benedetto N; Guerriero A
    Pediatria (Napoli); 1980 Dec; 88(4):521-31. PubMed ID: 6974847
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on cell-mediated cytotoxicity in patients with lymphocytic leukemia (author's transl)].
    Kotani H; Kumagai S; Tsunematsu T; Tatsumi E
    Rinsho Ketsueki; 1980 Sep; 21(9):1296-302. PubMed ID: 7452918
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lymphocyte transformation studies on lymphocytes and serum from children with acute lymphoid leukemia].
    Révész T; Szigeti R; Schuler D; Puskás E; Gyódi E
    Orv Hetil; 1974 May; 115(21):1211-3. PubMed ID: 4524425
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibody and complement-mediated cytotoxicity of nucleated cells. Inhibition by the sera of patients with acute lymphoblastic leukemia.
    Bock GH; Stitzel AE; Rittenhouse KW; Spitzer RE
    Transplantation; 1978 Dec; 26(6):415-9. PubMed ID: 282705
    [No Abstract]   [Full Text] [Related]  

  • 11. [Relation between immunological and morphological characteristics and the clinical course in children with acute lymphoblastic leukemia].
    Kubíková A; Habancová M; Valnícek S
    Cas Lek Cesk; 1984 May; 123(19):578-82. PubMed ID: 6589048
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of central nervous system irradiation in children with lymphoblastic leukemia on lymphocyte subpopulations and leukocyte migration inhibition indicators in the peripheral blood].
    Cesarz-Kruz E; Lukas A; Sroczyńska M; Lukas W; Sońta-Jakimczyk D
    Pediatr Pol; 1981 Sep; 56(9):1003-7. PubMed ID: 6976551
    [No Abstract]   [Full Text] [Related]  

  • 13. [Changes in the immune status in chronic lymphatic leukemia as dependent on the clinical stage].
    Costescu M; Moţoiu I; Dumitrescu A; Funduc I; Berceanu S
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(5):439-44. PubMed ID: 6143363
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cytotoxic activity of K cells in lymphocytic leukemia].
    Górska B; Konopka L; Seyfried H; Pawelski S
    Acta Haematol Pol; 1981; 12(1):7-15. PubMed ID: 7315149
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunotherapy in acute leukemias. Possible applications in children.
    Mahoney DH; Starling KA
    Am J Pediatr Hematol Oncol; 1981; 3(4):410-8. PubMed ID: 7036781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of the subclassifications of acute lymphoblastic leukemia.
    Douglass E
    Adv Pediatr; 1982; 29():183-202. PubMed ID: 6960645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characteristics of acute lymphoblastic leukemia of children with 0-cells in the bone marrow and a predominance of T- or B-cells in the peripheral blood].
    Lenskaia RV; Samochatova EV; Rumiantsev AG; Izotova TA
    Probl Gematol Pereliv Krovi; 1981 Jul; 26(7):20-4. PubMed ID: 6974356
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prognostic importance of studying the immune status of children with acute lymphoblastic leukemia. Preliminary report].
    Polák J; Plachý V; Turková M; Horácek J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1981; 24(5):621-6. PubMed ID: 6981196
    [No Abstract]   [Full Text] [Related]  

  • 19. Rapid transformation of atypical chronic lymphocytic leukemia to acute lymphoblastic leukemia.
    Haq AU; Williams DM; Clement JR; Bowen LM
    J Pak Med Assoc; 1987 Oct; 37(10):269-72. PubMed ID: 3121882
    [No Abstract]   [Full Text] [Related]  

  • 20. [A case of acute lymphoblastic leukemia with pre-B cell characteristics (author's transl)].
    Sugita K; Iwama Y; Mizushima W; Kato K; Umino T; Eguchi M; Furukawa T
    Rinsho Ketsueki; 1981 Dec; 22(12):1994-2000. PubMed ID: 6980300
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.